{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:53:05Z","timestamp":1791233585301,"version":"4.1.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"name":"Knut och Alice Wallenbergs Stiftelse","award":["2024-0177"],"award-info":[{"award-number":["2024-0177"]}],"id":[{"id":"https:\/\/ror.org\/004hzzk67","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1681\/asn.0000001207","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:01:21Z","timestamp":1786467681000},"page":"2085-2087","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Angiopoietin-2 and Progressive Kidney Disease"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1075-8563","authenticated-orcid":false,"given":"Marie","family":"Jeansson","sequence":"first","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet, Huddinge, and Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"10","key":"B1-20261005","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1681\/ASN.0000001089","article-title":"Cell-specific roles of angiopoietin-2 in CKD","volume":"37","author":"Luo","year":"2026","journal-title":"J Am Soc Nephrol."},{"issue":"5322","key":"B2-20261005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science."},{"issue":"7","key":"B3-20261005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","article-title":"Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning","volume":"87","author":"Davis","year":"1996","journal-title":"Cell."},{"issue":"21","key":"B4-20261005","doi-asserted-by":"crossref","first-page":"e190286","DOI":"10.1172\/JCI190286","article-title":"TIE2 activation by antibody-clustered endogenous angiopoietin-2 prevents capillary loss and fibrosis in experimental kidney disease","volume":"135","author":"Pietil\u00e4","year":"2025","journal-title":"J Clin Invest."},{"issue":"6","key":"B5-20261005","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1172\/JCI46322","article-title":"Angiopoietin-1 is essential in mouse vasculature during development and in response to injury","volume":"121","author":"Jeansson","year":"2011","journal-title":"J Clin Invest."},{"issue":"2","key":"B6-20261005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000488826","article-title":"Angiopoietin-2, renal deterioration, major adverse cardiovascular events and all-cause mortality in patients with diabetic nephropathy","volume":"43","author":"Tsai","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"B7-20261005","doi-asserted-by":"crossref","first-page":"163120","DOI":"10.1155\/2015\/163120","article-title":"Urinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus","volume":"2015","author":"Chen","year":"2015","journal-title":"Int J Endocrinol."},{"issue":"4","key":"B8-20261005","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.kint.2022.06.026","article-title":"Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells","volume":"102","author":"Chang","year":"2022","journal-title":"Kidney Int."},{"issue":"28","key":"B9-20261005","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1722317115","article-title":"Targeting beta1-integrin inhibits vascular leakage in endotoxemia","volume":"115","author":"Hakanpaa","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"B10-20261005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/biomedicines10061333","article-title":"Angiopoietin-2 inhibition of thrombomodulin-mediated anticoagulation-A novel mechanism that may contribute to hypercoagulation in critically ill COVID-19 patients","volume":"10","author":"Hultstrom","year":"2022","journal-title":"Biomedicines."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:00:17Z","timestamp":1791230417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001207","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}